Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    October 2018
  1. WANG Y, Yang L, Zhang J, Zhou M, et al
    Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Int J Oncol. 2018;53:1667-1680.
    PubMed     Text format     Abstract available


    August 2018
  2. WANG Z, Zhao X, Wang W, Liu Y, et al
    ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NFkappaB signaling pathway.
    Int J Oncol. 2018 Aug 10. doi: 10.3892/ijo.2018.4521.
    PubMed     Text format     Abstract available


  3. LUCAS J, Hsieh TC, Halicka HD, Darzynkiewicz Z, et al
    Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFkappaB signaling.
    Int J Oncol. 2018 Aug 1. doi: 10.3892/ijo.2018.4512.
    PubMed     Text format     Abstract available


    July 2018
  4. ZHOU L, Zhan ML, Tang Y, Xiao M, et al
    Effects of beta-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
    Int J Oncol. 2018 Jul 27. doi: 10.3892/ijo.2018.4506.
    PubMed     Text format     Abstract available


  5. KWAK B, Kim DU, Kim TO, Kim HS, et al
    MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Int J Oncol. 2018 Jul 26. doi: 10.3892/ijo.2018.4505.
    PubMed     Text format     Abstract available


  6. HUANG M, Geng Y, Deng Q, Li R, et al
    Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4502.
    PubMed     Text format     Abstract available


  7. CARRIERE PP, Kapur N, Mir H, Ward AB, et al
    Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.
    Int J Oncol. 2018 Jul 19. doi: 10.3892/ijo.2018.4489.
    PubMed     Text format     Abstract available


  8. ZHANG H, Yang W, Yan J, Zhou K, et al
    Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Int J Oncol. 2018 Jul 9. doi: 10.3892/ijo.2018.4475.
    PubMed     Text format     Abstract available


  9. ZHOU ZP, Wang LP, Hong ZS, Qiu CZ, et al
    Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Int J Oncol. 2018 Jul 5. doi: 10.3892/ijo.2018.4471.
    PubMed     Text format     Abstract available


  10. LIU M, Zhao G, Zhang D, An W, et al
    Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells.
    Int J Oncol. 2018 Jul 2. doi: 10.3892/ijo.2018.4465.
    PubMed     Text format     Abstract available


    June 2018
  11. SU P, Yang Y, Wang G, Chen X, et al
    Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Int J Oncol. 2018 Jun 29. doi: 10.3892/ijo.2018.4461.
    PubMed     Text format     Abstract available


  12. YAMAGUCHI M, Osuka S, Murata T
    Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
    Int J Oncol. 2018 Jun 28. doi: 10.3892/ijo.2018.4458.
    PubMed     Text format     Abstract available


  13. LEE SR, Jin H, Kim WT, Kim WJ, et al
    Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
    Int J Oncol. 2018 Jun 25. doi: 10.3892/ijo.2018.4453.
    PubMed     Text format     Abstract available


  14. CHEN ZP, Wei JC, Wang Q, Yang P, et al
    Long noncoding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA206 in colorectal cancer.
    Int J Oncol. 2018 Jun 22. doi: 10.3892/ijo.2018.4451.
    PubMed     Text format     Abstract available


  15. WANG B, Yin M, Cheng C, Jiang H, et al
    Decreased expression of miR4903p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4444.
    PubMed     Text format     Abstract available


  16. QIAN K, Huang H, Jiang J, Xu D, et al
    Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNAceRNA interaction network in colorectal cancer.
    Int J Oncol. 2018 Jun 18. doi: 10.3892/ijo.2018.4443.
    PubMed     Text format     Abstract available


  17. CHEN J, Gong C, Mao H, Li Z, et al
    E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Int J Oncol. 2018 Jun 5. doi: 10.3892/ijo.2018.4429.
    PubMed     Text format     Abstract available


    May 2018
  18. JIANG J, Liu HL, Tao L, Lin XY, et al
    Let7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
    Int J Oncol. 2018 May 23. doi: 10.3892/ijo.2018.4419.
    PubMed     Text format     Abstract available


  19. ZHANG Y, Feng Y, Ji D, Wang Q, et al
    TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4408.
    PubMed     Text format     Abstract available


  20. LEE DH, Won HR, Ryu HW, Han JM, et al
    The HDAC6 inhibitor ACY1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4405.
    PubMed     Text format     Abstract available


  21. SU MQ, Zhou YR, Rao X, Yang H, et al
    Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4402.
    PubMed     Text format     Abstract available


  22. LI X, Zhao X, Yang B, Li Y, et al
    Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.
    Int J Oncol. 2018 May 9. doi: 10.3892/ijo.2018.4400.
    PubMed     Text format     Abstract available


    April 2018
  23. PARK BK, Park JY, Kim TH, Kim D, et al
    Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
    Int J Oncol. 2018 Apr 26. doi: 10.3892/ijo.2018.4385.
    PubMed     Text format     Abstract available


  24. WU S, Wu F, Jiang Z
    Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Int J Oncol. 2018 Apr 2. doi: 10.3892/ijo.2018.4352.
    PubMed     Text format     Abstract available


  25. TOMIDA C, Yamagishi N, Nagano H, Uchida T, et al
    VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
    Int J Oncol. 2018;52:1350-1362.
    PubMed     Text format     Abstract available


    March 2018
  26. XIE Y, Liu Y, Li Q, Chen J, et al
    Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4328.
    PubMed     Text format     Abstract available


  27. JIN L, Si Y, Hong X, Liu P, et al
    Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4323.
    PubMed     Text format     Abstract available


  28. MATSUHASHI N, Takahashi T, Matsui S, Tanahashi T, et al
    A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4322.
    PubMed     Text format     Abstract available


  29. MAEDA Y, Takahashi H, Nakai N, Yanagita T, et al
    Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer.
    Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4308.
    PubMed     Text format     Abstract available


  30. SU C, Li D, Li N, Du Y, et al
    Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.
    Int J Oncol. 2018 Mar 6. doi: 10.3892/ijo.2018.4305.
    PubMed     Text format     Abstract available


  31. LI N, Mao D, Cao Y, Li H, et al
    Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4304.
    PubMed     Text format     Abstract available


    February 2018
  32. HE P, Li K, Li SB, Hu TT, et al
    Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.
    Int J Oncol. 2018 Feb 23. doi: 10.3892/ijo.2018.4284.
    PubMed     Text format     Abstract available


  33. BAI B, Xie B, Pan Z, Shan L, et al
    Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer.
    Int J Oncol. 2018 Feb 22. doi: 10.3892/ijo.2018.4281.
    PubMed     Text format     Abstract available


  34. FORSTER S, Hehlgans S, Rodel F, Otto B, et al
    Differential effects of alpha-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells.
    Int J Oncol. 2018 Feb 21. doi: 10.3892/ijo.2018.4279.
    PubMed     Text format     Abstract available


  35. NISHIZAWA Y, Konno M, Asai A, Koseki J, et al
    Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer.
    Int J Oncol. 2018;52:453-460.
    PubMed     Text format     Abstract available


  36. CHEN J, Lou Q, He L, Wen C, et al
    Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells.
    Int J Oncol. 2018 Feb 1. doi: 10.3892/ijo.2018.4264.
    PubMed     Text format     Abstract available


    January 2018
  37. NAGATA H, Ishihara S, Kishikawa J, Sonoda H, et al
    CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4240.
    PubMed     Text format     Abstract available


  38. LEE JY, Kim MS, Ju JE, Lee MS, et al
    Simvastatin enhances the radiosensitivity of p53deficient cells via inhibition of mouse double minute 2 homolog.
    Int J Oncol. 2018;52:211-218.
    PubMed     Text format     Abstract available


    November 2017
  39. OLEJNICZAK A, Szarynska M, Kmiec Z
    In vitro characterization of spheres derived from colorectal cancer cell lines.
    Int J Oncol. 2017 Nov 16. doi: 10.3892/ijo.2017.4206.
    PubMed     Text format     Abstract available


  40. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    PubMed     Text format     Abstract available


  41. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    PubMed     Text format     Abstract available


    October 2017
  42. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    PubMed     Text format     Abstract available


  43. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    PubMed     Text format     Abstract available


  44. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    PubMed     Text format     Abstract available


  45. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    PubMed     Text format     Abstract available


  46. LEE YJ, Kang YR, Lee SY, Jin Y, et al
    Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of bMyb and miRNA34a expression.
    Int J Oncol. 2017;51:1331-1342.
    PubMed     Text format     Abstract available


    September 2017
  47. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    PubMed     Text format     Abstract available


  48. SZARYNSKA M, Olejniczak A, Wierzbicki P, Kobiela J, et al
    FasR and FasL in colorectal cancer.
    Int J Oncol. 2017;51:975-986.
    PubMed     Text format     Abstract available


    August 2017
  49. KANG KA, Piao MJ, Ryu YS, Hyun YJ, et al
    Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4091.
    PubMed     Text format     Abstract available


  50. XU H, Zeng Y, Liu L, Gao Q, et al
    PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4090.
    PubMed     Text format     Abstract available


    July 2017
  51. PARK SY, Oh HH, Park YL, Yu HM, et al
    Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway.
    Int J Oncol. 2017 Jul 10. doi: 10.3892/ijo.2017.4070.
    PubMed     Text format     Abstract available


  52. XIANG S, Xiang T, Xiao Q, Li Y, et al
    Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/beta-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Int J Oncol. 2017 Jul 4. doi: 10.3892/ijo.2017.4064.
    PubMed     Text format     Abstract available


    June 2017
  53. WANG S, Shen Y, Qiu R, Chen Z, et al
    18 beta-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4059.
    PubMed     Text format     Abstract available


  54. CUSIMANO A, Balasus D, Azzolina A, Augello G, et al
    Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation.
    Int J Oncol. 2017 Jun 21. doi: 10.3892/ijo.2017.4049.
    PubMed     Text format     Abstract available


  55. FANG X, Hu T, Yin H, Yang J, et al
    Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4043.
    PubMed     Text format     Abstract available


  56. YANG Y, Wang G, Zhu D, Huang Y, et al
    Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4044.
    PubMed     Text format     Abstract available


  57. ZHENG J, He S, Qi J, Wang X, et al
    Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.
    Int J Oncol. 2017 Jun 13. doi: 10.3892/ijo.2017.4040.
    PubMed     Text format     Abstract available


    May 2017
  58. KIM JT, Weiss HL, Evers BM
    Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Int J Oncol. 2017 May 9. doi: 10.3892/ijo.2017.3990.
    PubMed     Text format     Abstract available


  59. LI H, Li D, Meng N
    Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3988.
    PubMed     Text format     Abstract available


  60. WANG Y, Sun N, Lu C, Bei Y, et al
    Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3987.
    PubMed     Text format     Abstract available


  61. ZHANG M, Ma F, Xie R, Wu Y, et al
    Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.
    Int J Oncol. 2017;50:1555-1566.
    PubMed     Text format     Abstract available


  62. CAO Y, Lin M, Bu Y, Ling H, et al
    p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration.
    Int J Oncol. 2017;50:1671-1682.
    PubMed     Text format     Abstract available


    March 2017
  63. YANG Q, Wang X, Tang C, Chen X, et al
    H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3941.
    PubMed     Text format     Abstract available


  64. NA K, Li K, Sang T, Wu K, et al
    Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3939.
    PubMed     Text format     Abstract available


  65. GONG H, Cao Y, Han G, Zhang Y, et al
    p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Int J Oncol. 2017 Mar 21. doi: 10.3892/ijo.2017.3922.
    PubMed     Text format     Abstract available


    February 2017
  66. CHEN QZ, Li Y, Shao Y, Zeng YH, et al
    TGF-beta1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3875.
    PubMed     Text format     Abstract available


  67. LU CC, Chu PY, Hsia SM, Wu CH, et al
    Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells.
    Int J Oncol. 2017;50:736-744.
    PubMed     Text format     Abstract available


  68. ZHAO J, Li G, Bo W, Zhou Y, et al
    Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis.
    Int J Oncol. 2017;50:613-621.
    PubMed     Text format     Abstract available


    January 2017
  69. LEE SY, Kim KA, Kim CH, Kim YJ, et al
    CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells.
    Int J Oncol. 2017;50:329-336.
    PubMed     Text format     Abstract available


  70. FUJII K, Luo Y, Fujiwara-Tani R, Kishi S, et al
    Pro-metastatic intracellular signaling of the elaidic trans fatty acid.
    Int J Oncol. 2017;50:85-92.
    PubMed     Text format     Abstract available


  71. NGUYEN HA, Kim SA
    2'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression.
    Int J Oncol. 2017;50:283-289.
    PubMed     Text format     Abstract available


  72. LIU K, Tang Z, Huang A, Chen P, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.
    Int J Oncol. 2017;50:252-262.
    PubMed     Text format     Abstract available


    December 2016
  73. KAWAI K, Uemura M, Munakata K, Takahashi H, et al
    Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3814.
    PubMed     Text format     Abstract available


  74. HATA T, Mokutani Y, Takahashi H, Inoue A, et al
    Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3813.
    PubMed     Text format     Abstract available


  75. YU H, Zhang H, Dong M, Wu Z, et al
    Metabolic reprogramming and AMPKalpha1 pathway activation by caulerpin in colorectal cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3794.
    PubMed     Text format     Abstract available


    November 2016
  76. HAGGBLAD SAHLBERG S, Mortensen AC, Haglof J, Engskog MK, et al
    Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3771.
    PubMed     Text format     Abstract available


  77. BAIK IH, Jo GH, Seo D, Ko MJ, et al
    Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-kappaB signaling axis.
    Int J Oncol. 2016;49:1953-1962.
    PubMed     Text format     Abstract available


    October 2016
  78. EL KHOURY F, Corcos L, Durand S, Simon B, et al
    Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    Int J Oncol. 2016 Oct 7. doi: 10.3892/ijo.2016.3725.
    PubMed     Text format     Abstract available


  79. GAO B, Shao Q, Choudhry H, Marcus V, et al
    [Corrigendum] Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016 Oct 6. doi: 10.3892/ijo.2016.3722.
    PubMed     Text format     Abstract available


  80. YI H, Ji D, Zhan T, Yao Y, et al
    Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.
    Int J Oncol. 2016;49:1415-26.
    PubMed     Text format     Abstract available


    September 2016
  81. YAMAMOTO H, Oshiro R, Ohtsuka M, Uemura M, et al
    [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Int J Oncol. 2016 Sep 16. doi: 10.3892/ijo.2016.3694.
    PubMed     Text format     Abstract available


  82. PARK GB, Chung YH, Gong JH, Jin DH, et al
    GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3679.
    PubMed     Text format     Abstract available


  83. LIANG F, Li Q, Li X, Li Z, et al
    TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.
    Int J Oncol. 2016;49:1046-56.
    PubMed     Text format     Abstract available


  84. GAO B, Shao Q, Choudhry H, Marcus V, et al
    Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016;49:1108-18.
    PubMed     Text format     Abstract available


  85. MUTO Y, Suzuki K, Kato T, Tsujinaka S, et al
    Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
    Int J Oncol. 2016;49:1057-67.
    PubMed     Text format     Abstract available


    August 2016
  86. WANG W, Liu J, Qi J, Zhang J, et al
    Downregulation of RLIP76 is associated with vincristine resistance in human colorectal cancer HCT-8/VCR cells.
    Int J Oncol. 2016 Aug 23. doi: 10.3892/ijo.2016.3672.
    PubMed     Text format     Abstract available


  87. LIU WM, Scott KA, Dennis JL, Kaminska E, et al
    Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.
    Int J Oncol. 2016;49:793-802.
    PubMed     Text format     Abstract available


  88. SONG GL, Jin CC, Zhao W, Tang Y, et al
    Regulation of the RhoA/ROCK/AKT/beta-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Int J Oncol. 2016;49:646-56.
    PubMed     Text format     Abstract available


  89. CHUNG SS, Oliva B, Dwabe S, Vadgama JV, et al
    Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
    Int J Oncol. 2016;49:487-98.
    PubMed     Text format     Abstract available


    July 2016
  90. XIAO Y, Zheng X, Huang A, Liu T, et al
    Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
    Int J Oncol. 2016 Jul 25. doi: 10.3892/ijo.2016.3629.
    PubMed     Text format     Abstract available


  91. YU Y, Yu X, Ma J, Tong Y, et al
    Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
    Int J Oncol. 2016;49:285-93.
    PubMed     Text format     Abstract available


  92. ISOZAKI T, Fujita M, Yamada S, Imadome K, et al
    Effects of carbon ion irradiation and X-ray irradiation on the ubiquitylated protein accumulation.
    Int J Oncol. 2016;49:144-52.
    PubMed     Text format     Abstract available


    June 2016
  93. KIM GT, Lee SH, Kim YM
    Torilis japonica extract-generated intracellular ROS induces apoptosis by reducing the mitochondrial membrane potential via regulation of the AMPK-p38 MAPK signaling pathway in HCT116 colon cancer.
    Int J Oncol. 2016 Jun 16. doi: 10.3892/ijo.2016.3578.
    PubMed     Text format     Abstract available


  94. LIN CL, Hsieh SL, Leung W, Jeng JH, et al
    2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside suppresses human colorectal cancer cell metastasis through inhibiting NF-kappaB activation.
    Int J Oncol. 2016 Jun 9. doi: 10.3892/ijo.2016.3574.
    PubMed     Text format     Abstract available


  95. LU M, Wang C, Wang J
    Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3565.
    PubMed     Text format     Abstract available


  96. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    PubMed     Text format     Abstract available


  97. GALATEANU B, Hudita A, Negrei C, Ion RM, et al
    Impact of multicellular tumor spheroids as an in vivolike tumor model on anticancer drug response.
    Int J Oncol. 2016;48:2295-302.
    PubMed     Text format     Abstract available


  98. ORLANDO A, Linsalata M, Russo F
    Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.
    Int J Oncol. 2016;48:2629-38.
    PubMed     Text format     Abstract available


    April 2016
  99. BASAK D, Punganuru SR, Srivenugopal KS
    Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
    Int J Oncol. 2016;48:1426-36.
    PubMed     Text format     Abstract available


    February 2016
  100. YOSHIOKA S, Mitsuyama K, Takedatsu H, Kuwaki K, et al
    Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.
    Int J Oncol. 2016;48:551-8.
    PubMed     Text format     Abstract available


  101. WOJAS-TUREK J, Szczygiel A, Kicielinska J, Rossowska J, et al
    Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma.
    Int J Oncol. 2016;48:493-505.
    PubMed     Text format     Abstract available


    January 2016
  102. TAKAHASHI H, Suzuki Y, Nishimura J, Haraguchi N, et al
    Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base.
    Int J Oncol. 2016;48:115-22.
    PubMed     Text format     Abstract available


    September 2015
  103. FUNAMIZU N, Lacy CR, Kamada M, Yanaga K, et al
    MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.
    Int J Oncol. 2015 Sep 22. doi: 10.3892/ijo.2015.3178.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: